Esoteric Testing Market

Report Code MD 5930
Published in Jun, 2024, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Esoteric Testing Market Size, Share & Trends by Type (Endocrinology, Oncology, Neurology, Genetic Tests, Autoimmune, Infectious Diseases), Technology (ELISA, CLIA, Flow Cytometry, NGS, RT-PCR, Chromatography, Spectrometry), Specimen (Blood, Urine) - Global Forecast to 2029

Overview

The size of global esoteric testing market in terms of revenue was estimated to be worth $32.2 billion in 2024 and is poised to reach $48.3 billion by 2029, growing at a CAGR of 8.5% from 2024 to 2029. The comprehensive research encompasses an exhaustive examination of industry trends, meticulous pricing analysis, patent scrutiny, insights derived from conferences and webinars, identification of key stakeholders, and a nuanced understanding of market purchasing dynamics. Growth in the market is primarily driven by the growing geriatric population, advancements in esoteric tests for personalized medicine, increasing research funding for precision medicine, and increase in drug and alcohol abuse and stringent laws mandating drug and alcohol testing.

Attractive Opportunities in the Esoteric Testing Market

Asia Pacific

Growth in the North American market can be attributed to economic growth in the countries of this region, large population base, and rising prevalence of chronic diseases.

The growth of this market can be attributed to the rising awareness regarding the use of diagnostic tests and automation.

Emerging markets are expected to offer significant growth opportunities for players operating in the esoteric testing market.

The Asia Pacific market is projected to hold the highest CAGR.

The global esoteric testing market is projected to reach USD 48.3 billion by 2029 from USD 32.2 billion in 2024, at a CAGR of 8.5%.

Global Esoteric Testing Market Dynamics

DRIVER: Increasing research funding for precision medicine, genetic analysis, and personalized medicine

Several research grants have been awarded for the research of genomics, precision medicine, and personalized medicine. These will support the understanding, diagnosis, and therapy development for rare molecules, helping esoteric testing laboratories to expand their diagnostic offerings.Technological, diagnostic, and healthcare solution developments are being driven by the growing investments in finance for R&D activities in the market. This initiative has the potential to improve patient outcomes, increase diagnostic accuracy, and address global health issues, thus contributing to market growth in the coming years.Recently, several organizations, authorities, and governments have deliberated their attention on personalized medicine. For instance, the new European Partnership for Personalised Medicine (EP PerMed), initiated on October 5, 2023, endeavors to enhance future healthcare provision for all individuals by focusing on personalized therapy.

RESTRAINT: High capital investments and low-cost-benefit ratio for biomarkers

The development of esoteric testing methods often leads to the discovery of new biomarkers. Esoteric testing helps researchers and doctors better understand how these biomarkers relate to health and disease. Significant capital investments are required for the discovery, development, and validation of biomarkers. This is a major factor restraining the growth of the biomarkers market and other related markets such as diagnostics (in vitro diagnostics or companion diagnostics) and personalized medicine.

 

OPPORTUNITY: Emerging technologies and advanced tests for screening and risk identification in esoteric testing

The increasing number of research studies on rare molecules has resulted in the development of several new technologies that hold great diagnostic potential for rare molecules. For instance, COLD-PCR helps in the diagnosis of rare mutations with the use of CO-amplification at lower denaturation temperature polymerase chain reaction (COLD-PCR) methods. This helps in the selective denaturation of wild-type-mutant heteroduplexes using the critical temperature, allowing the enrichment of rare mutations. These mutations are then analyzed by using techniques such as digital PCR, NGS, pyrosequencing, or Sanger sequencingOver the coming years, there will be notable growth in advanced tests for screening and risk assessment, spurred by the trend toward less invasive screening methods and their increasing clinical significance. In the longer term, as understanding deepens regarding the connections between genetic and proteomic markers and diseases, these tests will gain clinical relevance and actionable insights, leading to expanded utilization and positive healthcare outcomes.

CHALLENGE: Inaccuracies and misdiagnosis in diagnostic testing

Inaccuracies and misdiagnoses in esoteric testing can arise from a variety of factors, including inadequate sample extraction and testing, inconsistent or lacking test reporting, and retesting. The most prevalent infectious disorders impacted by diagnostic errors include urinary tract infections (UTIs), pleuro-pulmonary infections, tuberculosis (TB), upper respiratory tract infections (URTIs), and infections of the central nervous system (CNS). There was a considerable impact on clinical outcomes linked with errors related to tuberculosis (TB) and intra-abdominal infections (IAI). In approximately 33% of cases involving errors related to upper respiratory tract infections (URTIs), the incorrect causative pathogen was under consideration.According to the National Center for Biotechnology Information (NCBI), as of 2023, an estimated USD 50 billion to USD 60 billion is spent annually on unsuccessful cancer trials at the industry level. Improved target validation and more appropriate preclinical models are required to reduce attrition, with greater consideration for decision-making prior to the start of clinical trials.

Global Esoteric Testing Market Ecosystem Analysis

In 2023, the infectious diseases testing segment accounted for the largest share of the esoteric testing industry, by type Based on type, the esoteric testing market is segmented into infectious disease testing, autoimmune disease testing, endocrinology testing, oncology testing, genetic testing, toxicology and drug monitoring testing, neurology testing, and other types of testing. The high CAGR of this segment is attributed to the increasing prevalence of infectious diseases such as dengue, hepatitis B & C, malaria, HIV, and tuberculosis.

 

In 2023, the Enzyme-linked Immunosorbent Assay (ELISA) segment accounted for the largest share of the esoteric testing industry, by technology

Based on technology, the esoteric testing market is segmented into chemiluminescence immunoassay (CLIA), enzyme-linked immunosorbent assay (ELISA), real-time PCR, chromatography and mass spectrometry, flow cytometry, DNA sequencing and next-generation sequencing, and other technologies. Enhanced specificity and sensitivity via antigen-antibody reactions, coupled with high efficiency of simultaneous analyses, will drive the growth of this market.

In 2023, the market for Blood, serum and plasma specimens has the largest market share of the esoteric testing industry and is projected to have highest CAGR during the forecast period, by specimen

Based on specimens, the esoteric testing market is segmented into blood, serum, and plasma, urine, and other specimens. Blood is the most widely collected sample for esoteric testing procedures and is preferred for overall health screening as it provides information on various health conditions, such as genetic disorders, cardiovascular diseases, cancer, and diabetes. When used as a specimen in esoteric testing, blood, serum and plasma provides important insights into complex medical disorders, allowing for accurate diagnosis and customized treatment plans. Its importance in furthering medical research and customized treatment is highlighted by its capacity to identify complex biomarkers and genetic fingerprints.

North America region holds the largest share of the Esoteric Testing Market.

The global esoteric testing market is segmented into six major regions namely, North America, Europe, the Asia Pacific, Middle East & Africa, Latin America, and the GCC Countries. North America accounted for the largest share of the market in 2023. The growth of the North American market is mainly driven by its well-established esoteric laboratories, high per capita healthcare expenditure, and technologically advanced healthcare infrastructure.

 
 

Recent Developments of Esoteric Testing Market industry

  • In April 2024, Labcorp launched glial fibrillary acidic protein (GFAP), a critical blood-based biomarker for the early detection of neurodegenerative diseases and neurological injuries. In April 2024, Quest launched a new blood biomarker test for phosphorylated tau 217, or p-tau217. P-tau217 is useful for the early diagnosis of AD.
  • In March 2024, Labcorp launched pTau217 test to identify the presence or absence of phosphorylated tau 217 (pTau217), a pivotal blood biomarker designed to aid in the diagnosis of Alzheimer's disease and the subsequent monitoring of patients undergoing treatment with new Alzheimer's disease therapies.

Key Market Players

Want to explore hidden markets that can drive new revenue in Esoteric Testing Market?

Scope of the Report

Report Attribute Details
Market Revenue in 2024 $32.2 billion
Projected Revenue by 2029 $48.3 billion
Revenue Rate Poised to Grow at a CAGR of 8.5%
Market Driver Increasing research funding for precision medicine, genetic analysis, and personalized medicine
Market Opportunity Emerging technologies and advanced tests for screening and risk identification in esoteric testing

 

Key Questions Addressed by the Report

What is the projected market revenue value of the global esoteric testing market?
The global esoteric testing market boasts a total revenue value of $48.3 billion by 2029.
What is the estimated growth rate (CAGR) of the global esoteric testing market?
The global esoteric testing market has an estimated compound annual growth rate (CAGR) of 8.5% and a revenue size in the region of $32.2 billion in 2024.

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Esoteric Testing Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
27
RESEARCH METHODOLOGY
32
EXECUTIVE SUMMARY
45
PREMIUM INSIGHTS
49
MARKET OVERVIEW
53
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Growing geriatric population and increasing prevalence of chronic and infectious diseases
    - Increasing use of esoteric DNA sequencing technologies in precision medicine and early diagnosis of cancer
    - Advancements in esoteric tests for personalized medicine
    - Increasing research funding for precision medicine, genetic analysis, and personalized medicine
    - Growing number of collaborations
    - Increasing drug and alcohol abuse and stringent laws mandating drug and alcohol testing
    RESTRAINTS
    - Inadequate reimbursement
    - High capital investments and low-cost-benefit ratio for biomarkers
    OPPORTUNITIES
    - Emerging technologies and advanced tests for screening and risk identification in esoteric testing
    - Advances in understanding heterogeneity of diseases and safety signals
    - Growth opportunities in emerging economies
    CHALLENGES
    - Dearth of skilled professionals
    - Inaccuracies and misdiagnosis in diagnostic testing
  • 5.3 PRICING ANALYSIS
  • 5.4 VALUE CHAIN ANALYSIS
  • 5.5 SUPPLY CHAIN ANALYSIS
  • 5.6 ECOSYSTEM ANALYSIS OF ESOTERIC TESTING MARKET
    ROLE IN ECOSYSTEM
  • 5.7 REGULATORY OVERVIEW
    NORTH AMERICA
    - US
    - Canada
    EUROPE
    ASIA PACIFIC
    - Japan
    - India
    - China
    MIDDLE EAST
    - Saudi Arabia
    - UAE
  • 5.8 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Immunoassay techniques
    COMPLEMENTARY TECHNOLOGIES
    - Polymerase chain reaction
    ADJACENT TECHNOLOGIES
    - Mass spectrometry
    - Flow cytometry
  • 5.9 PATENT ANALYSIS
  • 5.10 KEY CONFERENCES & EVENTS IN 2024–2025
  • 5.11 PORTER’S FIVE FORCES ANALYSIS
    INTENSITY OF COMPETITIVE RIVALRY
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    THREAT OF SUBSTITUTES
    THREAT OF NEW ENTRANTS
  • 5.12 KEY STAKEHOLDERS AND BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    BUYING CRITERIA
  • 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
    REVENUE SHIFT IN ESOTERIC TESTING MARKET
  • 5.14 INVESTMENT AND FUNDING SCENARIO
ESOTERIC TESTING MARKET, BY TECHNOLOGY
83
  • 6.1 INTRODUCTION
  • 6.2 CHEMILUMINESCENCE IMMUNOASSAY
    HIGH THROUGHPUT AND REDUCED HUMAN ERROR TO DRIVE MARKET
  • 6.3 ENZYME-LINKED IMMUNOSORBENT ASSAY
    GROWING NUMBER OF DRUG DISCOVERY ACTIVITIES TO PROPEL MARKET
  • 6.4 REAL-TIME PCR
    INCREASING USE OF QPCR FOR VARIOUS DIAGNOSTIC AND RESEARCH PURPOSES TO SUPPORT MARKET GROWTH
  • 6.5 DNA SEQUENCING AND NEXT-GENERATION SEQUENCING
    RISING DEMAND FOR PERSONALIZED MEDICINE TO AID MARKET GROWTH
  • 6.6 FLOW CYTOMETRY
    RISING PREVALENCE OF CANCER, HIV, AND HEMATOLOGIC MALIGNANCIES TO DRIVE MARKET
  • 6.7 CHROMATOGRAPHY AND MASS SPECTROMETRY
    METHODOLOGICAL IMPROVEMENTS AND TECHNOLOGICAL INNOVATIONS TO BOOST MARKET GROWTH
  • 6.8 OTHER TECHNOLOGIES
ESOTERIC TESTING MARKET, BY TYPE
107
  • 7.1 INTRODUCTION
  • 7.2 ONCOLOGY TESTING
    HIGH BURDEN OF CANCER TO DRIVE MARKET
  • 7.3 AUTOIMMUNE DISEASE TESTING
    RISING PREVALENCE OF AUTOIMMUNE DISEASES TO SUPPORT MARKET GROWTH
  • 7.4 INFECTIOUS DISEASE TESTING
    RISING PREVALENCE OF INFECTIOUS DISEASES TO AID MARKET GROWTH
  • 7.5 ENDOCRINOLOGY TESTING
    INCREASING INCIDENCE OF DIABETES TO DRIVE ADOPTION OF ESOTERIC TESTS
  • 7.6 GENETIC TESTING
    ADVANCEMENTS IN GENOMICS AND PROTEOMICS TO SUPPORT MARKET GROWTH
  • 7.7 NEUROLOGY TESTING
    INCREASING PREVALENCE OF NEUROLOGICAL DISORDERS TO DRIVE MARKET
  • 7.8 TOXICOLOGY AND DRUG MONITORING TESTING
    INCREASING CASES OF DRUG ABUSE AND ILLICIT DRUG CONSUMPTION TO DRIVE DEMAND FOR ESOTERIC TESTING
  • 7.9 OTHER TYPES OF TESTING
ESOTERIC TESTING MARKET, BY SPECIMEN
137
  • 8.1 INTRODUCTION
  • 8.2 BLOOD, SERUM, AND PLASMA
    GREATER PREFERENCE AMONG HEALTHCARE PROVIDERS TO PROPEL MARKET
  • 8.3 URINE
    INCREASING UTILIZATION IN ILLICIT DRUG TESTING TO BOOST DEMAND
  • 8.4 OTHER SPECIMENS
ESOTERIC TESTING MARKET, BY END USER
149
  • 9.1 INTRODUCTION
  • 9.2 INDEPENDENT AND REFERENCE LABORATORIES
    LARGEST AND FASTEST-GROWING END USERS OF ESOTERIC TESTS
  • 9.3 HOSPITAL-BASED LABORATORIES
    INCREASING NUMBER OF SPECIALTY DIAGNOSTIC TESTS PERFORMED TO SUPPORT MARKET GROWTH
ESOTERIC TESTING MARKET, BY REGION
157
  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    NORTH AMERICA: RECESSION IMPACT
    US
    - Favorable policies for molecular diagnostic providers to support market growth
    CANADA
    - Lack of proper reimbursements for diagnostic tests to hamper market growth
  • 10.3 EUROPE
    EUROPE: RECESSION IMPACT
    GERMANY
    - Favorable government policies to propel market
    FRANCE
    - Rising demand for early disease diagnosis to drive market
    ITALY
    - Rapidly growing geriatric population to favor market growth
    UK
    - Favorable investment scenario to drive market
    SPAIN
    - High burden of chronic and infectious diseases to drive adoption of esoteric tests
    REST OF EUROPE
  • 10.4 ASIA PACIFIC
    ASIA PACIFIC: RECESSION IMPACT
    JAPAN
    - Presence of well-developed healthcare system to favor market growth
    CHINA
    - China to register highest growth rate in Asia Pacific esoteric testing market during forecast period
    INDIA
    - Improving healthcare system to support market growth
    AUSTRALIA
    - Increasing incidence of chronic diseases and increasing focus on preventive healthcare to propel market
    REST OF ASIA PACIFIC
  • 10.5 LATIN AMERICA
    LATIN AMERICA: RECESSION IMPACT
    BRAZIL
    - Presence of large and well-developed pharmaceutical industry to drive market
    MEXICO
    - Growth in private healthcare sector to propel market
    REST OF LATIN AMERICA
  • 10.6 MIDDLE EAST & AFRICA
    IMPROVEMENTS IN HEALTHCARE INFRASTRUCTURE TO DRIVE MARKET
  • 10.7 MIDDLE EAST & AFRICA: RECESSION IMPACT
  • 10.8 GCC COUNTRIES
    HEALTHCARE INFRASTRUCTURE DEVELOPMENT TO DRIVE MARKET
    GCC COUNTRIES: RECESSION IMPACT
COMPETITIVE LANDSCAPE
224
  • 11.1 OVERVIEW
  • 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 11.3 REVENUE SHARE ANALYSIS
  • 11.4 MARKET SHARE ANALYSIS
  • 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2023
  • 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    PROGRESSIVE COMPANIES
    STARTING BLOCKS
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • 11.7 COMPETITIVE SCENARIO
    SERVICE LAUNCHES
    DEALS
    EXPANSIONS
  • 11.8 VALUATION AND FINANCIAL METRICS OF ESOTERIC TESTING VENDORS
COMPANY PROFILES
242
  • 12.1 MAJOR PLAYERS
    LABCORP
    - Business overview
    - Services offered
    - Recent developments
    - MnM view
    QUEST DIAGNOSTICS
    - Business overview
    - Services offered
    - Recent developments
    - MnM view
    OPKO HEALTH, INC.
    - Business overview
    - Services offered
    - Recent developments
    - MnM view
    H.U. GROUP HOLDINGS, INC.
    - Business overview
    - Services offered
    - Recent developments
    SONIC HEALTHCARE LIMITED
    - Business overview
    - Services offered
    - Recent developments
    MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (MFMER)
    - Business overview
    - Services offered
    EUROFINS SCIENTIFIC
    - Business overview
    - Services offered
    - Recent developments
    STANFORD HEALTH CARE
    - Business overview
    - Services offered
    - Recent developments
    FOUNDATION MEDICINE, INC.
    - Business overview
    - Services offered
    - Recent developments
    KINDSTAR GLOBALGENE TECHNOLOGY, INC.
    - Business overview
    - Services offered
    GEORGIA ESOTERIC & MOLECULAR LABORATORY, LLC
    - Business overview
    - Services offered
    THYROCARE TECHNOLOGIES LIMITED
    - Business overview
    - Services offered
    ACM GLOBAL LABORATORIES
    - Business overview
    - Services offered
  • 12.2 OTHER PLAYERS
    NMS LABS
    HEALTHQUEST ESOTERICS
    CERBA XPERT
    LEOLABS, INC.
    FLOW HEALTH
    INVITAE CORPORATION
    MYRIAD GENETICS, INC.
    ARUP LABORATORIES
    FULGENT GENETICS
    BIOMONTR LABS
    LABGENOMICS
APPENDIX
286
  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 RISK ASSESSMENT
  • TABLE 2 GLOBAL INCIDENCE OF INFECTIOUS DISEASES
  • TABLE 3 ESOTERIC TESTS INDICATED FOR CHRONIC AND INFECTIOUS DISEASES
  • TABLE 4 AVERAGE SELLING PRICE OF ESOTERIC TESTS, BY REGION
  • TABLE 5 ESOTERIC TESTING MARKET: ROLE IN ECOSYSTEM
  • TABLE 6 ACCREDITATION BODIES IN EUROPE
  • TABLE 7 KEY PLAYERS OFFERING ESOTERIC TESTS WITH ADVANCED TECHNOLOGIES
  • TABLE 8 ESOTERIC TESTING MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS, 2O24–2025
  • TABLE 9 ESOTERIC TESTING MARKET: PORTER’S FIVE FORCES ANALYSIS
  • TABLE 10 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS (%)
  • TABLE 11 KEY BUYING CRITERIA FOR ESOTERIC TESTING END USERS
  • TABLE 12 ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 13 ESOTERIC TESTING MARKET FOR CHEMILUMINESCENCE IMMUNOASSAY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 14 NORTH AMERICA: ESOTERIC TESTING MARKET FOR CHEMILUMINESCENCE IMMUNOASSAY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 15 EUROPE: ESOTERIC TESTING MARKET FOR CHEMILUMINESCENCE IMMUNOASSAY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 16 ASIA PACIFIC: ESOTERIC TESTING MARKET FOR CHEMILUMINESCENCE IMMUNOASSAY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 17 LATIN AMERICA: ESOTERIC TESTING MARKET FOR CHEMILUMINESCENCE IMMUNOASSAY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 18 EXAMPLES OF ESOTERIC ELISA TESTS
  • TABLE 19 ESOTERIC TESTING MARKET FOR ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 20 NORTH AMERICA: ESOTERIC TESTING MARKET FOR ENZYME-LINKED IMMUNOSORBENT ASSAY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 21 EUROPE: ESOTERIC TESTING MARKET FOR ENZYME-LINKED IMMUNOSORBENT ASSAY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 22 ASIA PACIFIC: ESOTERIC TESTING MARKET FOR ENZYME-LINKED IMMUNOSORBENT ASSAY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 23 LATIN AMERICA: ESOTERIC TESTING MARKET FOR ENZYME-LINKED IMMUNOSORBENT ASSAY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 24 ESOTERIC TESTING MARKET FOR REAL-TIME PCR, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 25 NORTH AMERICA: ESOTERIC TESTING MARKET FOR REAL-TIME PCR, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 26 EUROPE: ESOTERIC TESTING MARKET FOR REAL-TIME PCR, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 27 ASIA PACIFIC: ESOTERIC TESTING MARKET FOR REAL-TIME PCR, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 28 LATIN AMERICA: ESOTERIC TESTING MARKET FOR REAL-TIME PCR, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 29 EXAMPLES OF ESOTERIC TESTS FOR DNA SEQUENCING
  • TABLE 30 ESOTERIC TESTING MARKET FOR DNA SEQUENCING AND NEXT-GENERATION SEQUENCING, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 31 NORTH AMERICA: ESOTERIC TESTING MARKET FOR DNA SEQUENCING AND NEXT-GENERATION SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 32 EUROPE: ESOTERIC TESTING MARKET FOR DNA SEQUENCING AND NEXT-GENERATION SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 33 ASIA PACIFIC: ESOTERIC TESTING MARKET FOR DNA SEQUENCING AND NEXT-GENERATION SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 34 LATIN AMERICA: ESOTERIC TESTING MARKET FOR DNA SEQUENCING AND NEXT-GENERATION SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 35 ESOTERIC TESTING MARKET FOR FLOW CYTOMETRY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 36 NORTH AMERICA: ESOTERIC TESTING MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 37 EUROPE: ESOTERIC TESTING MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 38 ASIA PACIFIC: ESOTERIC TESTING MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 39 LATIN AMERICA: ESOTERIC TESTING MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 40 ESOTERIC TESTING MARKET FOR CHROMATOGRAPHY AND MASS SPECTROMETRY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 41 NORTH AMERICA: ESOTERIC TESTING MARKET FOR CHROMATOGRAPHY AND MASS SPECTROMETRY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 42 EUROPE: ESOTERIC TESTING MARKET FOR CHROMATOGRAPHY AND MASS SPECTROMETRY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 43 ASIA PACIFIC: ESOTERIC TESTING MARKET FOR CHROMATOGRAPHY AND MASS SPECTROMETRY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 44 LATIN AMERICA: ESOTERIC TESTING MARKET FOR CHROMATOGRAPHY AND MASS SPECTROMETRY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 45 ESOTERIC TESTING MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 46 NORTH AMERICA: ESOTERIC TESTING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 47 EUROPE: ESOTERIC TESTING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 48 ASIA PACIFIC: ESOTERIC TESTING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 49 LATIN AMERICA: ESOTERIC TESTING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 50 ESOTERIC TESTING MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 51 PREVALENCE OF CANCER AMONG MALES, 2022
  • TABLE 52 PREVALENCE OF CANCER AMONG FEMALES, 2022
  • TABLE 53 EXAMPLES OF ESOTERIC TESTS FOR CANCER DIAGNOSIS
  • TABLE 54 ESOTERIC ONCOLOGY TESTING MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 55 NORTH AMERICA: ESOTERIC ONCOLOGY TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 56 EUROPE: ESOTERIC ONCOLOGY TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 57 ASIA PACIFIC: ESOTERIC ONCOLOGY TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 58 LATIN AMERICA: ESOTERIC ONCOLOGY TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 59 ESOTERIC AUTOIMMUNE DISEASE TESTING MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 60 NORTH AMERICA: ESOTERIC AUTOIMMUNE DISEASE TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 61 EUROPE: ESOTERIC AUTOIMMUNE DISEASE TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 62 ASIA PACIFIC: ESOTERIC AUTOIMMUNE DISEASE TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 63 LATIN AMERICA: ESOTERIC AUTOIMMUNE DISEASE TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 64 EXAMPLES OF ESOTERIC TESTS FOR INFECTIOUS DISEASES
  • TABLE 65 ESOTERIC INFECTIOUS DISEASE TESTING MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 66 NORTH AMERICA: ESOTERIC INFECTIOUS DISEASE TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 67 EUROPE: ESOTERIC INFECTIOUS DISEASE TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 68 ASIA PACIFIC: ESOTERIC INFECTIOUS DISEASE TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 69 LATIN AMERICA: ESOTERIC INFECTIOUS DISEASE TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 70 ESOTERIC ENDOCRINOLOGY TESTING MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 71 NORTH AMERICA: ESOTERIC ENDOCRINOLOGY TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 72 EUROPE: ESOTERIC ENDOCRINOLOGY TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 73 ASIA PACIFIC: ESOTERIC ENDOCRINOLOGY TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 74 LATIN AMERICA: ESOTERIC ENDOCRINOLOGY TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 75 ESOTERIC GENETIC TESTING MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 76 NORTH AMERICA: ESOTERIC GENETIC TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 77 EUROPE: ESOTERIC GENETIC TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 78 ASIA PACIFIC: ESOTERIC GENETIC TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 79 LATIN AMERICA: ESOTERIC GENETIC TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 80 EXAMPLES OF ESOTERIC TESTS FOR NEUROLOGICAL DISORDERS
  • TABLE 81 ESOTERIC NEUROLOGY TESTING MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 82 NORTH AMERICA: ESOTERIC NEUROLOGY TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 83 EUROPE: ESOTERIC NEUROLOGY TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 84 ASIA PACIFIC: ESOTERIC NEUROLOGY TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 85 LATIN AMERICA: ESOTERIC NEUROLOGY TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 86 ESOTERIC TOXICOLOGY AND DRUG MONITORING TESTING MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 87 NORTH AMERICA: ESOTERIC TOXICOLOGY AND DRUG MONITORING TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 88 EUROPE: ESOTERIC TOXICOLOGY AND DRUG MONITORING TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 89 ASIA PACIFIC: ESOTERIC TOXICOLOGY AND DRUG MONITORING TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 90 LATIN AMERICA: ESOTERIC TOXICOLOGY AND DRUG MONITORING TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 91 ESOTERIC TESTING MARKET FOR OTHER TYPES OF TESTING, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 92 NORTH AMERICA: ESOTERIC TESTING MARKET FOR OTHER TYPES OF TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 93 EUROPE: ESOTERIC TESTING MARKET FOR OTHER TYPES OF TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 94 ASIA PACIFIC: ESOTERIC TESTING MARKET FOR OTHER TYPES OF TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 95 LATIN AMERICA: ESOTERIC TESTING MARKET FOR OTHER TYPES OF TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 96 ESOTERIC TESTING MARKET, BY SPECIMEN, 2022–2029 (USD MILLION)
  • TABLE 97 ESOTERIC TESTING MARKET FOR BLOOD, SERUM, AND PLASMA SPECIMENS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 98 NORTH AMERICA: ESOTERIC TESTING MARKET FOR BLOOD, SERUM, AND PLASMA SPECIMENS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 99 EUROPE: ESOTERIC TESTING MARKET FOR BLOOD, SERUM, AND PLASMA SPECIMENS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 100 ASIA PACIFIC: ESOTERIC TESTING MARKET FOR BLOOD, SERUM, AND PLASMA SPECIMENS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 101 LATIN AMERICA: ESOTERIC TESTING MARKET FOR BLOOD, SERUM, AND PLASMA SPECIMENS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 102 ESOTERIC TESTING MARKET FOR URINE SPECIMENS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 103 NORTH AMERICA: ESOTERIC TESTING MARKET FOR URINE SPECIMENS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 104 EUROPE: ESOTERIC TESTING MARKET FOR URINE SPECIMENS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 105 ASIA PACIFIC: ESOTERIC TESTING MARKET FOR URINE SPECIMENS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 106 LATIN AMERICA: ESOTERIC TESTING MARKET FOR URINE SPECIMENS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 107 ESOTERIC TESTING MARKET FOR OTHER SPECIMENS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 108 NORTH AMERICA: ESOTERIC TESTING MARKET FOR OTHER SPECIMENS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 109 EUROPE: ESOTERIC TESTING MARKET FOR OTHER SPECIMENS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 110 ASIA PACIFIC: ESOTERIC TESTING MARKET FOR OTHER SPECIMENS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 111 LATIN AMERICA: ESOTERIC TESTING MARKET FOR OTHER SPECIMENS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 112 ESOTERIC TESTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 113 ESOTERIC TESTING MARKET FOR INDEPENDENT AND REFERENCE LABORATORIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 114 NORTH AMERICA: ESOTERIC TESTING MARKET FOR INDEPENDENT AND REFERENCE LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 115 EUROPE: ESOTERIC TESTING MARKET FOR INDEPENDENT AND REFERENCE LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 116 ASIA PACIFIC: ESOTERIC TESTING MARKET FOR INDEPENDENT AND REFERENCE LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 117 LATIN AMERICA: ESOTERIC TESTING MARKET FOR INDEPENDENT AND REFERENCE LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 118 ESOTERIC TESTING MARKET FOR HOSPITAL-BASED LABORATORIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 119 NORTH AMERICA: ESOTERIC TESTING MARKET FOR HOSPITAL-BASED LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 120 EUROPE: ESOTERIC TESTING MARKET FOR HOSPITAL-BASED LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 121 ASIA PACIFIC: ESOTERIC TESTING MARKET FOR HOSPITAL-BASED LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 122 LATIN AMERICA: ESOTERIC TESTING MARKET FOR HOSPITAL-BASED LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 123 ESOTERIC TESTING MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 124 NORTH AMERICA: ESOTERIC TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 125 NORTH AMERICA: ESOTERIC TESTING MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 126 NORTH AMERICA: ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 127 NORTH AMERICA: ESOTERIC TESTING MARKET, BY SPECIMEN, 2022–2029 (USD MILLION)
  • TABLE 128 NORTH AMERICA: ESOTERIC TESTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 129 US: INCIDENCE, MORTALITY, AND PREVALENCE, BY CANCER TYPE, 2022
  • TABLE 130 US: ESOTERIC TESTING MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 131 US: ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 132 US: ESOTERIC TESTING MARKET, BY SPECIMEN, 2022–2029 (USD MILLION)
  • TABLE 133 US: ESOTERIC TESTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 134 CANADA: ESOTERIC TESTING MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 135 CANADA: ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 136 CANADA: ESOTERIC TESTING MARKET, BY SPECIMEN, 2022–2029 (USD MILLION)
  • TABLE 137 CANADA: ESOTERIC TESTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 138 EUROPE: ESOTERIC TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 139 EUROPE: ESOTERIC TESTING MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 140 EUROPE: ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 141 EUROPE: ESOTERIC TESTING MARKET, BY SPECIMEN, 2022–2029 (USD MILLION)
  • TABLE 142 EUROPE: ESOTERIC TESTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 143 GERMANY: INCIDENCE, MORTALITY, AND PREVALENCE, BY CANCER TYPE, 2022
  • TABLE 144 GERMANY: ESOTERIC TESTING MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 145 GERMANY: ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 146 GERMANY: ESOTERIC TESTING MARKET, BY SPECIMEN, 2022–2029 (USD MILLION)
  • TABLE 147 GERMANY: ESOTERIC TESTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 148 FRANCE: ESOTERIC TESTING MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 149 FRANCE: ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 150 FRANCE: ESOTERIC TESTING MARKET, BY SPECIMEN, 2022–2029 (USD MILLION)
  • TABLE 151 FRANCE: ESOTERIC TESTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 152 ITALY: ESOTERIC TESTING MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 153 ITALY: ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 154 ITALY: ESOTERIC TESTING MARKET, BY SPECIMEN, 2022–2029 (USD MILLION)
  • TABLE 155 ITALY: ESOTERIC TESTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 156 UK: ESOTERIC TESTING MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 157 UK: ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 158 UK: ESOTERIC TESTING MARKET, BY SPECIMEN, 2022–2029 (USD MILLION)
  • TABLE 159 UK: ESOTERIC TESTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 160 SPAIN: ESOTERIC TESTING MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 161 SPAIN: ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 162 SPAIN: ESOTERIC TESTING MARKET, BY SPECIMEN, 2022–2029 (USD MILLION)
  • TABLE 163 SPAIN: ESOTERIC TESTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 164 REST OF EUROPE: CANCER INCIDENCE, BY COUNTRY, 2022 VS. 2045
  • TABLE 165 REST OF EUROPE: ESOTERIC TESTING MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 166 REST OF EUROPE: ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 167 REST OF EUROPE: ESOTERIC TESTING MARKET, BY SPECIMEN, 2022–2029 (USD MILLION)
  • TABLE 168 REST OF EUROPE: ESOTERIC TESTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 169 ASIA PACIFIC: ESOTERIC TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 170 ASIA PACIFIC: ESOTERIC TESTING MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 171 ASIA PACIFIC: ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 172 ASIA PACIFIC: ESOTERIC TESTING MARKET, BY SPECIMEN, 2022–2029 (USD MILLION)
  • TABLE 173 ASIA PACIFIC: ESOTERIC TESTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 174 JAPAN: CANCER INCIDENCE, MORTALITY, AND PREVALENCE, BY CANCER TYPE, 2022
  • TABLE 175 JAPAN: ESOTERIC TESTING MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 176 JAPAN: ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 177 JAPAN: ESOTERIC TESTING MARKET, BY SPECIMEN, 2022–2029 (USD MILLION)
  • TABLE 178 JAPAN: ESOTERIC TESTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 179 CHINA: CANCER INCIDENCE, MORTALITY, AND PREVALENCE, BY CANCER TYPE, 2022
  • TABLE 180 CHINA: ESOTERIC TESTING MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 181 CHINA: ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 182 CHINA: ESOTERIC TESTING MARKET, BY SPECIMEN, 2022–2029 (USD MILLION)
  • TABLE 183 CHINA: ESOTERIC TESTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 184 INDIA: CANCER INCIDENCE, MORTALITY, AND PREVALENCE, BY CANCER TYPE, 2022
  • TABLE 185 INDIA: ESOTERIC TESTING MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 186 INDIA: ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 187 INDIA: ESOTERIC TESTING MARKET, BY SPECIMEN, 2022–2029 (USD MILLION)
  • TABLE 188 INDIA: ESOTERIC TESTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 189 AUSTRALIA: ESOTERIC TESTING MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 190 AUSTRALIA: ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 191 AUSTRALIA: ESOTERIC TESTING MARKET, BY SPECIMEN, 2022–2029 (USD MILLION)
  • TABLE 192 AUSTRALIA: ESOTERIC TESTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 193 REST OF ASIA PACIFIC: ESOTERIC TESTING MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 194 REST OF ASIA PACIFIC: ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 195 REST OF ASIA PACIFIC: ESOTERIC TESTING MARKET, BY SPECIMEN, 2022–2029 (USD MILLION)
  • TABLE 196 REST OF ASIA PACIFIC: ESOTERIC TESTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 197 LATIN AMERICA: ESOTERIC TESTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 198 LATIN AMERICA: ESOTERIC TESTING MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 199 LATIN AMERICA: ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 200 LATIN AMERICA: ESOTERIC TESTING MARKET, BY SPECIMEN, 2022–2029 (USD MILLION)
  • TABLE 201 LATIN AMERICA: ESOTERIC TESTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 202 BRAZIL: ESOTERIC TESTING MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 203 BRAZIL: ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 204 BRAZIL: ESOTERIC TESTING MARKET, BY SPECIMEN, 2022–2029 (USD MILLION)
  • TABLE 205 BRAZIL: ESOTERIC TESTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 206 MEXICO: ESOTERIC TESTING MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 207 MEXICO: ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 208 MEXICO: ESOTERIC TESTING MARKET, BY SPECIMEN, 2022–2029 (USD MILLION)
  • TABLE 209 MEXICO: ESOTERIC TESTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 210 REST OF LATIN AMERICA: ESOTERIC TESTING MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 211 REST OF LATIN AMERICA: ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 212 REST OF LATIN AMERICA: ESOTERIC TESTING MARKET, BY SPECIMEN, 2022–2029 (USD MILLION)
  • TABLE 213 REST OF LATIN AMERICA: ESOTERIC TESTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 214 AFRICA: CANCER INCIDENCE, MORTALITY, AND PREVALENCE, BY CANCER TYPE, 2022
  • TABLE 215 MIDDLE EAST & AFRICA: ESOTERIC TESTING MARKET, BY TEST, 2022–2029 (USD MILLION)
  • TABLE 216 MIDDLE EAST & AFRICA: ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 217 MIDDLE EAST & AFRICA: ESOTERIC TESTING MARKET, BY SPECIMEN, 2022–2029 (USD MILLION)
  • TABLE 218 MIDDLE EAST & AFRICA: ESOTERIC TESTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 219 GCC COUNTRIES: ESOTERIC TESTING MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 220 GCC COUNTRIES: ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 221 GCC COUNTRIES: ESOTERIC TESTING MARKET, BY SPECIMEN, 2022–2029 (USD MILLION)
  • TABLE 222 GCC COUNTRIES: ESOTERIC TESTING MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 223 OVERVIEW OF STRATEGIES ADOPTED BY KEY MARKET PLAYERS
  • TABLE 224 ESOTERIC TESTING MARKET: DEGREE OF COMPETITION
  • TABLE 225 COMPANY FOOTPRINT
  • TABLE 226 TYPE FOOTPRINT
  • TABLE 227 TECHNOLOGY FOOTPRINT
  • TABLE 228 END-USER FOOTPRINT
  • TABLE 229 REGIONAL FOOTPRINT
  • TABLE 230 ESOTERIC TESTING MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 231 ESOTERIC TESTING MARKET: SERVICE LAUNCHES, JANUARY 2021–APRIL 2024
  • TABLE 232 ESOTERIC TESTING MARKET: DEALS, JANUARY 2021–APRIL 2024
  • TABLE 233 ESOTERIC TESTING MARKET: EXPANSIONS, JANUARY 2021–APRIL 2024
  • TABLE 234 LABCORP: BUSINESS OVERVIEW
  • TABLE 235 LABCORP: SERVICES OFFERED
  • TABLE 236 LABCORP: SERVICE LAUNCHES, JANUARY 2021–APRIL 2024
  • TABLE 237 LABCORP: DEALS, JANUARY 2021–APRIL 2024
  • TABLE 238 LABCORP: EXPANSIONS, JANUARY 2021–APRIL 2024
  • TABLE 239 QUEST DIAGNOSTICS: BUSINESS OVERVIEW
  • TABLE 240 QUEST DIAGNOSTICS: SERVICES OFFERED
  • TABLE 241 QUEST DIAGNOSTICS: SERVICE LAUNCHES, JANUARY 2021–APRIL 2024
  • TABLE 242 QUEST DIAGNOSTICS: DEALS, JANUARY 2021–APRIL 2024
  • TABLE 243 QUEST DIAGNOSTICS: EXPANSIONS, JANUARY 2021–APRIL 2024
  • TABLE 244 OPKO HEALTH, INC.: BUSINESS OVERVIEW
  • TABLE 245 OPKO HEALTH, INC.: SERVICES OFFERED
  • TABLE 246 OPKO HEALTH, INC.: DEALS, JANUARY 2021–APRIL 2024
  • TABLE 247 H.U. GROUP HOLDINGS, INC.: BUSINESS OVERVIEW
  • TABLE 248 H.U. GROUP HOLDINGS, INC.: SERVICES OFFERED
  • TABLE 249 H.U. GROUP HOLDINGS, INC.: DEALS, JANUARY 2021–APRIL 2024
  • TABLE 250 SONIC HEALTHCARE LIMITED: BUSINESS OVERVIEW
  • TABLE 251 SONIC HEALTHCARE LIMITED: SERVICES OFFERED
  • TABLE 252 SONIC HEALTHCARE LIMITED: DEALS
  • TABLE 253 MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH: BUSINESS OVERVIEW
  • TABLE 254 MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH: SERVICES OFFERED
  • TABLE 255 EUROFINS SCIENTIFIC: BUSINESS OVERVIEW
  • TABLE 256 EUROFINS SCIENTIFIC: SERVICES OFFERED
  • TABLE 257 EUROFINS SCIENTIFIC: SERVICE LAUNCHES, JANUARY 2021–APRIL 2024
  • TABLE 258 EUROFINS SCIENTIFIC: DEALS, JANUARY 2021–APRIL 2024
  • TABLE 259 STANFORD HEALTH CARE: BUSINESS OVERVIEW
  • TABLE 260 STANFORD HEALTH CARE: SERVICES OFFERED
  • TABLE 261 STANFORD HEALTH CARE: SERVICE LAUNCHES, JANUARY 2021–APRIL 2024
  • TABLE 262 STANFORD HEALTH CARE: DEALS, JANUARY 2021–APRIL 2024
  • TABLE 263 FOUNDATION MEDICINE, INC.: BUSINESS OVERVIEW
  • TABLE 264 FOUNDATION MEDICINE, INC.: SERVICES OFFERED
  • TABLE 265 FOUNDATION MEDICINE, INC.: DEALS, JANUARY 2021–APRIL 2024
  • TABLE 266 KINDSTAR GLOBALGENE TECHNOLOGY, INC.: BUSINESS OVERVIEW
  • TABLE 267 KINDSTAR GLOBALGENE TECHNOLOGY, INC.: SERVICES OFFERED
  • TABLE 268 GEORGIA ESOTERIC & MOLECULAR LABORATORY, LLC: BUSINESS OVERVIEW
  • TABLE 269 GEORGIA ESOTERIC & MOLECULAR LABORATORY, LLC: SERVICES OFFERED
  • TABLE 270 THYROCARE TECHNOLOGIES LIMITED: BUSINESS OVERVIEW
  • TABLE 271 THYROCARE TECHNOLOGIES LIMITED: SERVICES OFFERED
  • TABLE 272 ACM GLOBAL LABORATORIES: BUSINESS OVERVIEW
  • TABLE 273 ACM GLOBAL LABORATORIES: SERVICES OFFERED
LIST OF FIGURES
 
  • FIGURE 1 ESOTERIC TESTING MARKET SEGMENTATION
  • FIGURE 2 ESOTERIC TESTING MARKET: RESEARCH DESIGN
  • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5 COMPANY REVENUE ESTIMATION
  • FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 7 ESOTERIC TESTING MARKET: TOP-DOWN APPROACH
  • FIGURE 8 DATA TRIANGULATION METHODOLOGY
  • FIGURE 9 ESOTERIC TESTING MARKET, BY TYPE, 2024 VS. 2029 (USD BILLION)
  • FIGURE 10 ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2024 VS. 2029 (USD BILLION)
  • FIGURE 11 ESOTERIC TESTING MARKET, BY SPECIMEN, 2024 VS. 2029 (USD BILLION)
  • FIGURE 12 ESOTERIC TESTING MARKET, BY END USER, 2024 VS. 2029 (USD BILLION)
  • FIGURE 13 GEOGRAPHICAL SNAPSHOT OF ESOTERIC TESTING MARKET
  • FIGURE 14 RISING PREVALENCE OF CHRONIC AND INFECTIOUS DISEASES TO DRIVE MARKET
  • FIGURE 15 ELISA SEGMENT ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC MARKET IN 2023
  • FIGURE 16 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
  • FIGURE 17 ASIA PACIFIC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD
  • FIGURE 18 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD
  • FIGURE 19 ESOTERIC TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 20 INCIDENCE OF CANCER, BY REGION, 2022 VS. 2030 VS. 2040 (MILLION)
  • FIGURE 21 INCIDENCE OF DIABETES, BY REGION, 2021 VS. 2030 VS. 2045 (MILLION)
  • FIGURE 22 GERIATRIC POPULATION, BY REGION, 2022 VS. 2050 (%)
  • FIGURE 23 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
  • FIGURE 24 ESOTERIC TESTING MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 25 ESOTERIC TESTING MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 26 KEY PLAYERS IN ESOTERIC TESTING MARKET ECOSYSTEM
  • FIGURE 27 PATENT ANALYSIS FOR ESOTERIC TESTING MARKET (JANUARY 2013– DECEMBER 2023)
  • FIGURE 28 ESOTERIC TESTING MARKET: PORTER’S FIVE FORCES ANALYSIS
  • FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS
  • FIGURE 30 KEY BUYING CRITERIA FOR ESOTERIC TESTING END USERS
  • FIGURE 31 NORTH AMERICA: ESOTERIC TESTING MARKET SNAPSHOT
  • FIGURE 32 ASIA PACIFIC: ESOTERIC TESTING MARKET SNAPSHOT
  • FIGURE 33 REVENUE SHARE ANALYSIS OF KEY PLAYERS IN ESOTERIC TESTING MARKET, 2021–2023 (USD MILLION)
  • FIGURE 34 ESOTERIC TESTING MARKET SHARE ANALYSIS, 2023
  • FIGURE 35 ESOTERIC TESTING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 36 ESOTERIC TESTING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 37 EV/EBITDA OF TOP 3 COMPANIES IN ESOTERIC TESTING MARKET
  • FIGURE 38 EV/REVENUE OF TOP 3 COMPANIES IN ESOTERIC TESTING MARKET
  • FIGURE 39 1-YEAR PRICE TOTAL RETURN OF TOP 3 COMPANIES IN ESOTERIC TESTING MARKET
  • FIGURE 40 5-YEAR BETA OF TOP 3 COMPANIES IN ESOTERIC TESTING MARKET
  • FIGURE 41 LABCORP: COMPANY SNAPSHOT (2023)
  • FIGURE 42 QUEST DIAGNOSTICS: COMPANY SNAPSHOT (2023)
  • FIGURE 43 OPKO HEALTH, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 44 H.U. GROUP HOLDINGS, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 45 SONIC HEALTHCARE LIMITED: COMPANY SNAPSHOT (2023)
  • FIGURE 46 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2023)
  • FIGURE 47 KINDSTAR GLOBALGENE TECHNOLOGY, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 48 THYROCARE TECHNOLOGIES LIMITED: COMPANY SNAPSHOT (2023)

To determine the current size of the esoteric testing market, this study engaged in four main activities. A comprehensive study was conducted using secondary research methods to gather data about the market, its parent market, and its peer markets. The next stage involved conducting primary research to confirm these conclusions, assumptions, and sizing with industry experts throughout the value chain. A combination of top-down and bottom-up methods was used to assess the overall market size. The market sizes of segments and subsegments were then estimated using data triangulation techniques and market breakdown.

The four steps involved in estimating the market size are

Collecting Secondary Data

Within the secondary data collection process, a range of secondary sources were reviewed so as to identify and gather data for this study, including regulatory bodies, databases (like D&B Hoovers, Bloomberg Business, and Factiva), white papers, certified publications, articles by well-known authors, annual reports, press releases, and investor presentations of companies.

Collecting Primary Data

During the primary research phase, a comprehensive approach was adopted, involving interviews with a diverse array of sources from both the supply and demand sides. These interviews aimed to gather qualitative and quantitative data essential for compiling this report. Primary sources primarily comprised industry experts spanning core and related sectors, as well as favored suppliers, manufacturers, distributors, service providers, technology innovators, and entities associated with all facets of this industry's value chain. In-depth interviews were meticulously conducted with a range of primary respondents, including key industry stakeholders, subject-matter authorities, C-level executives representing pivotal market players, and industry advisors. The objective was to obtain and authenticate critical qualitative and quantitative insights and to evaluate future potentialities comprehensively.

A breakdown of the primary respondents is provided below:

Breakdown of Primary Participants:

Esoteric Testing Market  Size, and Share

Note 1: Others include sales, marketing, and product managers.

Note 2: Tiers of companies are defined based on their total revenue. As of 2023, Tier 1 = >USD 5 billion, Tier 2 = USD 500 million to USD 5 billion, and Tier 3 = <USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

COMPANY NAME

DESIGNATION

HealthQuest Esoterics

Strategic Manager

Labcorp

Advisor

Sonic Healthcare

Senior Director

OPKO health

VP Marketing

Market Size Estimation

All major service providers offering various esoteric services were identified at the global/regional level. Revenue mapping was done for the major players and was extrapolated to arrive at the global market value of each type of segment. The market value of esoteric testing market was also split into various segments and subsegments at the region and country level based on:

  • Services mapping of various service providers for each type in esoteric testing market at the regional and country-level
  • Relative adoption pattern of each esoteric testing market among key application segments at the regional and/or country-level
  • Detailed primary research to gather qualitative and quantitative information related to segments and subsegments at the regional and/or country level.
  • Detailed secondary research to gauge the prevailing market trends at the regional and/or country level

Global Esoteric Testing Market Size: Bottom Up Approach

Esoteric Testing Market  Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Global Esoteric Testing Market Size: Top-Down Approach

Esoteric Testing Market  Size, and Share

Data Triangulation

After arriving at the overall market size applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Esoteric testing is the diagnosis, detection, or quantitation of rare analytes in a sample. These tests are offered by specialized laboratories equipped with sophisticated diagnostic instruments and reagents, such as reference & independent laboratories and hospital-based laboratories. Many large and medium-sized commercial laboratories, companies, and physician office laboratories outsource these complex tests to reference and independent laboratories. These laboratories are limited in number, and the tests offered are costlier than routine diagnostic tests.

Key Stakeholders

  • Manufacturers and Vendors of Esoteric Testing Instruments and Consumables
  • Esoteric Testing Laboratories and Service Providers
  • Pharmaceutical and Biopharmaceutical Companies
  • Diagnostic Associations
  • Research Associations Involved in the Research of Infectious and Chronic Diseases
  • Various Research and Consulting Firms
  • Distributors of Esoteric Instruments and Consumables
  • Contract Research Manufacturers of Esoteric Testing Consumables
  • Healthcare Institutes
  • Research Institutes

Report Objectives

  • To provide detailed information about the factors influencing the market growth (such as drivers, trends, opportunities, and challenges)
  • To define, describe, segment, and forecast the in esoteric testing market by type, by technology, by specimen, by end user, and by region
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall esoteric testing market
  • To forecast the size of the esoteric testing market in six main regions along with their respective key countries, namely, North America, Europe, the Asia Pacific, Latin America, Middle East & Africa, and GCC Countries.
  • To profile key players in the esoteric testing market and comprehensively analyze their core competencies and market shares
  • To track and analyze competitive developments, such as service launches; expansions; acquisitions, and collaborations, of the leading players in the esoteric testing market.
  • To benchmark players within the esoteric testing market using the Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business and product strategy

Available Customizations

MarketsandMarkets offers the following customizations for this market report

Country Information

  • Additional country-level analysis of the esoteric testing market

Company profiles

  • Additional 3 company profiles of players operating in the esoteric testing market.

Product Analysis

Previous Versions of this Report

Esoteric Testing Market by Type (Infectious Disease, Endocrinology, Oncology, Toxicology, Immunology, Genetic Testing), Technology (MS, CLIA, ELISA, PCR), End User (Independent & Reference Laboratories, Hospital Laboratories) - Global Forecast to 2026

Report Code MD 5930
Published in Jun, 2021, By MarketsandMarkets™

Esoteric Testing Market by Type (Infectious Disease, Endocrinology, Oncology, Toxicology, Immunology, Genetic Testing), Technology (MS, CLIA, ELISA, PCR), End User (Independent & Reference Laboratories, Hospital Laboratories) - Global Forecast to 2026

Report Code MD 5930
Published in Jan, 2018, By MarketsandMarkets™
"Our USP is "providing game-changing business opportunities reports with free customization" - so please feel free to provide us with your specific areas of interest / business challenges in much greater detail !!"

We appreciate your interest in this report. Once you fill out the form, you'll be immediately directed to an exclusive solution tailored to your needs. This high-value offering can help boost your revenue by 30% - a must-see opportunity for anyone looking to maximize growth.


By clicking the "Submit" button, you are agreeing to the Terms of Use and Privacy Policy.

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Esoteric Testing Market

Hank

May, 2022

What are the Size, Share, industry Growth, Statistics and opportunities in Esoteric Testing Market with forecasts including 2026, 2027, 2028, 2030 .

Margaret

Mar, 2022

How the key players are dominating the global Esoteric Testing Market?.

Sandra

Mar, 2022

How much percent share does the each region holds of the Global Esoteric Testing Market?.

DMCA.com Protection Status